Abstract
In periodontal practice microbial results of periodontal test kits for identification of key pathogens are an aid in the treatment planning. Information on the performance of commercially available test kits is therefore essential for the clinician. In this retrospective analysis three commercially available qPCR kits for detection and quantification of selected periodontal bacterial species were compared, using 100 clinical samples from patients with untreated periodontitis. The analysis involved two separate comparisons in which kit A (LabOral Diagnostics, The Netherlands) was compared with kit B (Advanced Dental Diagnostics, The Netherlands), and with kit C (OralDent diagnostics, The Netherlands). Analytic procedures for detection and quantification of selected periodontal bacterial species were carried out according to the instructions of the laboratories. Kit A detected target species more often, and absolute numbers of bacterial cells were higher than with kit B. A high degree of similarity was found between the test outcomes by kit A and kit C. All three kits performed satisfactory but small and significant differences exist between kits.
Similar content being viewed by others
Introduction
Periodontitis is a ubiquitous and irreversible biofilm initiated inflammatory condition1. The microorganisms in the dental biofilm are considered to be involved in the pathogenesis, and in particular the subgingival bacteria play an important role in initiation and progression2. The microenvironment of the subgingival pocket harbors a wide diversity of bacterial species3. Host factors contribute to the composition of dental plaque and to susceptibility to disease4. An imbalance in the total microbiota due to ecological stress results in an enrichment of some “oral pathogens” or disease-related micro-organisms. The World Workshop in Periodontics has provided a list of bacterial species that are associated with progression of periodontal attachment loss5. This selection of etiologically important bacterial species was based on prevalence in disease, immunological response, relevant virulence factors, experimental infections, and response upon treatment.
Potential pathogens associated with progression of disease include, among others, the strict anaerobic species Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Treponema denticola, Parvimonas micra, Fusobacterium nucleatum and the capnophilic Aggregatibacter actinomycetemcomitans5,6,7,8,9. Additional bacteria that are difficult to grow have been identified as marker species of periodontitis based on DNA sequencing10. For example Filifactor alocis7,11,12,13 which has the potential to withstand oxidative stress14 and to induce strong pro-inflammatory responses15. Most suspected periodontal pathogens occur in microbial clusters some of which have been associated with disease progression. The most prominent cluster in this respect consists of the anaerobic and highly proteolytic species P. gingivalis, T. forsythia and T. denticola, and is often referred to as the red complex16,17. P. gingivalis has also been indicated as keystone pathogen because it can manipulate the native immune system of the host, by which it can facilitate its own survival and multiplication as well that as of the entire microbial community, and trigger inflammation18. The composition of the subgingival biofilm differs between individual patients. This can be the basis for a differentiated approach of periodontal therapy. In this respect, special attention has been paid to periodontal infections associated with A. actinomycetemcomitans, a species that has been implicated in periodontitis formerly classified as localized and generalized aggressive, and in refractory periodontitis19,20. Though the mere presence of A. actinomycetemcomitans cannot discriminate between different stages of periodontitis22. While pretreatment microbiological examination, especially for the detection of A. actinomycetemcomitans, was found to be a valuable screening method for identifying complex treatment need in adult patients with advanced periodontitis23. In patients harboring A. actinomycetemcomitans mechanical treatment does not predictably lead to resolution of the periodontal inflammation21.
Treatment of periodontitis is based on reduction of the total periodontal bacterial load, which is achieved by mechanical supra- and subgingival debridement. Open debridement can be achieved by periodontal surgery that provides direct access to the root for biofilm removal. Occasionally this therapy fails when periodontal attachment loss continues after treatment, or recurs after periods of remission24. This unsatisfying observation has led to the additional use of topical or systemic antibiotics in periodontal therapy25,26. The choice for systemic antimicrobial therapy is often based on clinical parameters but the use of microbiological diagnosis for decision making and choice of antibiotics has long been advocated25,27,28. This is based on the notion that differences in bacterial composition of the subgingival biofilm may require different treatment approaches, including the choice of adjuvant antibiotic therapy. This tailored approach connects with the medical aim to provide personalized medicine to the patient, and assist in prevention of under- and over treatment.
Different techniques have been applied to detect and quantify bacterial periodontal marker organisms such as bacterial cultivation, immunoassays, specific enzymatic tests and various molecular techniques. Commercially available test systems make use of DNA-chip technology, DNA-DNA hybridization, and qualitative and quantitative polymerase chain reaction (qPCR). Compared to bacterial culture, real time PCR provides a rapid diagnostic tool with which enables detection of small numbers of bacterial species in clinical specimens29. Untch and Schlagenhauf30 compared three different test systems using clinical periodontal samples, and concluded superiority in specificity and intra-test reproducibility of the qPCR technology. Comparison of three different qPCR test kits and using mock bacterial communities also revealed significant differences between the results31.
Multiple commercially available test kits based on qPCR are now available in Europe. For a dental care professional it is important to know that the performance of a qPCR test kit depends on the design of primers and probes, and may results in different outcomes between test systems. It is however difficult for the clinician to select which kit is most suitable without any clinically relevant data. The objective of the present practice based retrospective analysis was to compare three commercially available diagnostic qPCR kits for the detection and quantification of periodontal bacteria, using samples from patients diagnosed with moderate to severe adult periodontitis.
Material and Methods
Patients
Patients involved in the analysis had been referred because of periodontal problems by their general dentist to the specialist Clinic for Periodontology Utrecht, The Netherlands from 2013 up to 2016. The diagnostic procedure is described in an earlier paper32. In short, the clinical diagnosis was based on intra- and extra oral assessment, full mouth periodontal charting, and a relevant set of radiographs. The parameters that were collected included probing pocket depth (PPD; measurements were rounded off to the nearest millimeter), bleeding on pocket probing (BOP) scored as absent or present), and furcation involvement (using a PQ0W6 pocket probe and PQ2NM furcation probe, Hu-Friedy Inc.). PPD and BOP were recorded at six sites (mesio-buccal, buccal, disto-buccal, mesio-lingual, lingual and disto-lingual). Eligible patients met with the following criteria:
–no periodontal treatment in the past 6 months,
–no use of local or systemic antibiotics in the past three months,
–not pregnant,
–consenting to use the obtained data for research purposes.
Design
Diagnostic microbiological testing is part of the standard treatment protocol in this clinic. The comparison of the outcome of three commercial microbiological test was initiated as an attempt for the clinic to decide which laboratory to work with. It consisted of two legs. In the first part, kit A used as benchmark33 was compared with kit B using a convenience sample of 50 clinical cases obtained from untreated periodontitis patients. In the second part of the analysis, kit A was compared with kit C using 50 clinical samples. The patient related data were retrospectively analyzed for the present paper.
Test kits
Three commercially available qPCR test kits were used in this retrospective analysis: the Periodontal DNA Test (LabOral Diagnostics, Houten, The Netherlands, kit A), the Periodontal Bacteria Test (Advanced Dental Diagnostics B.V., Malden, The Netherlands, kit B), and the test system of Carpegen Perio Diagnostik (Carpegen GmbH, Münster, Germany, kit C), made available in the Netherlands by OralDent diagnostics. Each laboratory produced independent test results according to their own method of processing the microbial samples.
Sampling
Subgingival biofilm samples were obtained using sterile endodontic paper points and a standardized sampling protocol34. Subgingival microbial specimens were taken from the site exhibiting the deepest probing depth, and showing bleeding on probing in each quadrant of the dentition35,36,37. The four sample sites were first isolated with cotton rolls, supragingival plaque was mechanically removed, after which two sterile paper points were inserted simultaneously to the depth of the periodontal pocket, and left in situ for approximately 10 s prior to removal. After extraction from the pocket one paper point from each of the four pockets was collected in a sterile vial of Kit A, and the other in a vial from either kit B or kit C. Samples were forwarded the same day under routine conditions by regular mail to each of the respective microbiology laboratories.
Laboratory procedures
Samples were processed according to laboratory’s protocol. All three laboratory tested for the presence and numbers of A. actinomycetemcomitans, P. gingivalis, P. intermedia, T. forsythia, P. micra, F. nucleatum, and T. denticola. Test kit A is also equipped to detect and quantify F. alocis.
Statistical analyses
The primary outcome was presence or absence of the test species. Secondary outcome was the number of bacterial cells of each detected species. The absolute numbers of bacterial cells of the test species in positive tested samples were log transformed (See online supplementary file 1). The means and standard deviations of all species were calculated as detected by the different test kits. The unpaired two-sided Student T-test was used to analyze differences in mean absolute numbers of bacterial cells. Sensitivity, specificity, together with 95% confidence intervals, % agreement, kappa values and McNemar Test χ2-test were calculated using R (4.03) via RStudio 1.3.109338 and jamovi 1.0739. Bonferroni corrections for multiple comparisons were applied where appropriate. A p-value of < 0.05 was considered statistically significant.
Ethical approval
All procedures performed in relation to the treatment of patients were in accordance with the ethical standards of the Clinic for Periodontology Utrecht and with the 1964 Helsinki declaration and its later amendments. Diagnostic microbiological testing is part of the standard protocol in this clinic. The study protocol (as registered under protocol number 202043) was reviewed by the Ethical Committee of the Academic Centre for Dentistry Amsterdam (ETC-ACTA) and judged to be exempt from the need for further ethical approval as it falls outside of the scope of the Medical Research Involving Human Subjects act (WMO). This study meets the ethical guidelines at ACTA (see online supplementary file 2).
Informed consent
All data were procured retrospectively from the treatment records and entered anonymously in an Excel file. Patients had provided informed consent in advance that data related to their treatment could anonymously be used for further analysis.
Results
In total 100 patients, referred to the Clinic for Periodontology Utrecht were sampled. In Table 1 the participants are ranked according to the Classification of Periodontitis40. Five patients were classified as stage II, 53 stage III and 42 stage IV. Of these 36 were graded as B and 64 as C. Table 2 shows the frequencies of periodontal pathogens detected by the kits A, B, and C. Table 3 presents the mean log number (standard deviation) of each bacterial species established in trial 1 and 2 by kit A, B, and C. Table 4 and 5 show the number of positive and negative samples for each species detected for kit A, kit B, and kit C.
In trial 1, 50 consecutive clinical samples were analyzed with kit A and kit B. The number of positive samples of each of the test species were higher for all species with kit A except for T. denticola . A large difference was found in the frequency of samples that tested positive for P. intermedia (62% vs 22%). The majority (> 85%) of the samples gave positive results for P. micra, F. nucleatum, and T. forsythia whereas for other species a much lower positive outcome was observed i.e. A. actinomytcetemcomitans, P. gingivalis, T. denticola (Table 2). The number of bacterial cells per species detected was significantly higher with kit A as compared to kit B except for T. denticola positive samples (Table 3). Table 4 shows the number of positive and negative samples for each species detected by kit A and kit B. The mean number of T. denticola cells in positive tested samples was not different between kit A and kit B (log 5,48, SD 0.75 vs 5.59 SD 0.67, P = 0.06).
In trial 2 the frequencies of positive outcomes for the periodontal pathogens were rather similar except for F. nucleatum, which was higher with test kit A (100% vs 88%). T. denticola was found positive in lower frequency with test kit A (54% vs 92%) as compared to kit C.
A. actinomycetemcomitans emerged as positive outcome in approximately one third of the samples. With test kit C one additional sample was found positive. P. gingivalis was detected in approximately half of the samples with 3 additional positive samples by kit A. P. intermedia was detected in two additional samples by kit A. The mean log number of A. actinomycetemcomitans, P. gingivalis, P. intermedia, T. forsythia, F. nucleatum, and P. micra cells did not differ between kit A and kit C (Table 3). The mean log number of detected T. denticola cells was significantly higher with kit C compared to kit A (5.8 vs 2.7, P < 0.0001). Table 5 shows the number of positive and negative samples for each species detected by kit A and kit C.
In Table 6, data of the statistical analysis with respect to sensitivity, specificity, % agreement, and kappa values are presented. In the comparison of kit A versus B sensitivity varied between 36 and 100%. The χ2—test showed a significant difference with respect to the detection of P. intermedia. The % agreement associated with this was 60% and kapa value was 0.30. In the comparison of kit A versus C sensitivity varied between 88 and 100%. The χ2—test showed a significant difference with respect to the detection of T. denticola for which the specificity was 17%. The % agreement associated with this was 60% and kapa value was 0.15.
Only test kit A was designed to detect and enumerate F. alocis. The frequency of positive test outcomes of this periodontal species was 82% and 86% in part 1 and 2 of this analysis (Table 2). The detected number of F. alocis was log 6.42 (SD 0.93) and 6.13 (SD 0.88) respectively (Table 3).
Discussion
The microbiology of periodontal diseases has been the focus of intense investigation for several decades41. Various commercially available microbiological tests are available for the clinician to support in the diagnosis of periodontal disease42. Clinical findings ultimately determine the decision to treat, or retreat, for which the outcome of microbiological testing may provide guidance; e.g. whether or not to use antibiotics as adjuncts to mechanical therapy.
In the present retrospective analysis we compared three commercially available test kits for the detection and quantification of selected bacterial species associated with destructive periodontal disease. All three test systems are based on real time and quantitative polymerase chain reactions. Untch and Schlagenhauf30 compared DNA-DNA hybridization, semi-quantitative PCR, and qPCR using 20 samples from patients suffering from severe periodontitis. They showed superiority of the qPCR technique over hybridization and the semi-quantitative PCR, including the intra-test reproducibility. Their study results formed for the periodontal practice the basis for initiating the present comparisons of commercially available laboratory test. The analysis is the first to compare three qPCR kits using a relatively large number of clinical subgingival samples (N = 100). The most obvious differences were found between kit A and kit B. Both the prevalence of the selected species as well as the total mean number of bacterial cells per species was lower as compared to kit A. With kit A, a high prevalence of F. alocis was found in both trials. This species has been described as a strong biomarker for periodontitis due to its high subgingival detection in disease, and its absence in periodontal health7,43.
The data used for the present analysis were obtained from subgingival samples from patients that had been referred by their general dentist for periodontal disease. The level of disease was by the referring dentists considered to be beyond the control of what could be effectively treated in their general dental practice. Classification showed that these referrals were mainly Stage III and IV periodontitis patients with a fast majority being grade as C40. This provides a reflection of the population under investigation.
The information generated by microbiological analysis of subgingival plaque that has been collected from a periodontally diseased site, is highly dependent on the technique that is used for bacterial sampling. There are two primary methods by which a patient's subgingival plaque can be collected for subsequent analysis: removal using a curette or adsorption onto endodontic paper points44. Both require careful removal of supragingival plaque at the sampling site as was the case. The differences in frequency of positive outcomes are however not likely explained by the sampling technique since two endodontic paper points were entered simultaneously into the periodontal pockets before separating them for analysis.
The differences between kit A and C were less pronounced, with a slightly higher rate of positive outcomes for three species by kit A, for two species by kit B. Remarkable were the differences in frequency of P. intermedia and T. denticola by the three kits. For instance for T. denticola the highest frequency was observed by kit C (92%), and the lowest by kit A (44–54%). Differences in outcomes between kits may be explained by differences in DNA isolation, volume input in the PCR, the DNA multiplication program used and the composition of the mastermix. Also the use of nested PCR may influence test outcome, because this technique requires opening of the amplified DNA with risks of contamination, and increased reamplification of a specific amplicons from the first PCR amplification.
Microbiological diagnosis of destructive periodontal disease may aid in clinical decision making, and for the selection of adjuvant antimicrobial treatment25. The use of antibiotics has especially been advocated in the treatment of A. actinomycetemcomitans-associated aggressive periodontitis27,45,46 and P. gingivalis/T. forsythia/ T.denticola-associated periodontitis47. Therefore detection of these pathogens is essential in microbiological diagnosis. Relative to kit A, kit B did not detect P. gingivalis in four samples and in three samples by kit C. This indicates that further improvement and optimization of primer/probe sets is warranted. The reproducibility of the outcome of microbial analyses of periodontal samples between separate laboratories has been tested in the past using anaerobic culture technique, and was found to be rather poor48. A survey among European diagnostic oral microbiology laboratories demonstrated that the reason for this might be the lack of harmonization of laboratory processing methods49. The present analysis shows that the PCR technique has significantly improved the reproducibility between different laboratories.
Historically, inflammatory periodontal diseases have been recognized as being primarily of bacterial origin50. Contemporary microbiome studies indicate that individual pathogens are not always obvious etiologic agents in periodontitis/peri-implantitis. It is currently understood that these diseases manifest as a result of a disequilibrium in the dynamic relationships among biofilm, host, and microenvironment51. It should therefore be recognized that the results obtained from the analysis of the subgingival plaque do not provide sufficient information regarding the risk of disease progression. In this respect the absence of potential periodontal pathogens has been proposed as a better predictor for no further loss of attachment52. Clinical decisions should therefore never be made in isolation of clinical findings44. In the periodontal ecosystem diverse bacteria (or specific combinations of genes within the community) may be able to fulfill distinct roles that converge to form and stabilize a disease-provoking microbiota. Because the information gathered with microbiological tests is limited to a relatively small number of pathogens, current tests may fail to identify a keystone pathogen with a dysbiotic role for a particular patient. In the current context of elevated resistance to antibiotic medication there should however be a focus on microbiological diagnosis. This interest should inspire development of new and better laboratory techniques and interpretations, and ensure a successful and predictable treatment result for all types of periodontitis cases27. For instance a recent publication investigated the role of biologic markers in modelling periodontitis disease progression. The practical implication emerging from this research was that baseline biomarker expression profiles in biological fluids, and levels of P. gingivalis and T. forsythia in subgingival plaque, could predict outcomes associated with periodontal care prior to clinical detection53. Also with deep sequencing technologies novel periodontal disease-associated bacteria emerge7,43,54, one of which (Candidatus Bacteroides Periocalifornicus) was found in a recent study to have a strong association with the well-known pathogenic "red complex" that resides in deep periodontal pockets54.
The following limitations were recognized;
-
With a lack of suitable information it was not possible to perform a sample size calculation ‘a priori’. Consequently a convenience sample of 50 was used, the number of samples which was considered to provide a clinically relevant outcome.
-
It can not be ruled out that there were no differences in the microorganism being harvested by the two paper points even though they were inserted simultaneously.
In conclusion, the three commercially available qPCR test kits to support the microbiological diagnosis of periodontitis showed small but significant difference with respect to detection and quantification of selected bacterial species. Test kit A tested more frequently positive for P. gingivalis as compared to kit B and kit C and less frequently for T. denticola. Optimization of laboratory procedures and of primer/probe sets is needed to further improve the performance of all three test kits in order to provide a reliable reflection of actual presence and numbers of selected periodontal pathogens in the subgingival biofilm.
References
Chapple, I. L. et al. Primary prevention of periodontitis: Managing gingivitis. J. Clin. Periodontol. 42(Suppl. 16), S71-76 (2015).
Ge, X., Rodriguez, R., Trinh, M., Gunsolley, J. & Xu, P. Oral microbiome of deep and shallow dental pockets in chronic periodontitis. PLoS ONE 8, e65520 (2013).
Paster, B. J. et al. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183, 3770–3783 (2001).
Mason, M. R., Nagaraja, H. N., Camerlengo, T., Joshi, V. & Kumar, P. S. Deep sequencing identifies ethnicity-specific bacterial signatures in the oral microbiome. PLoS ONE 8, e77287 (2013).
Zambon, J. J. Periodontal diseases: Microbial factors. Ann. Periodontol. 1, 879–925 (1996).
Nørskov-Lauritsen, N., Claesson, R., Birkeholm Jensen, A., Åberg, C. H. & Haubek, D. Aggregatibacter actinomycetemcomitans: Clinical significance of a pathobiont subjected to ample changes in classification and nomenclature. Pathogens 18, E243 (2019).
Griffen, A. L. et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 6, 1176–1185 (2012).
How, K. Y., Song, K. P. & Chan, K. G. Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum line. Front. Microbiol. 9, 53 (2016).
Timmerman, M.F., Van der Weijden, G.A., Arief, E.M., Armand, S., Abbas, F., et al. Untreated periodontal disease in Indonesian adolescents. Subgingival microbiota in relation to experienced progression of periodontitis. J. Clin. Periodontol. 28, 617–627 (2001).
Pérez-Chaparro, P. J. et al. Newly identified pathogens associated with periodontitis: A systematic review. J. Dent. Res. 93, 846–858 (2014).
Chen, H. et al. A Filifactor alocis-centered co-occurrence group associates with periodontitis across different oral habitats. Sci. Rep. 12, 9053 (2015).
Paster, B. J. & Dewhirst, F. E. Molecular microbial diagnosis. Periodontol. 2000(51), 38–44 (2009).
Shaw, L. et al. Distinguishing the signals of gingivitis and periodontitis in supragingival plaque: A cross-sectional cohort study in Malawi. Appl. Environ. Microbiol. 82, 6057–6067 (2016).
Aruni, A. W. et al. Filifactor alocis a new emerging periodontal pathogen. Microbes Infect. 17, 517–530 (2015).
Moffatt, C. E., Whitmore, S. E., Griffen, A. L., Leys, E. J. & Lamont, R. J. Filifactor alocis interactions with gingival epithelial cells. Mol. Oral Microbiol. 26, 365–373 (2011).
Byrne, S. J. et al. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral. Microbiol. Immunol. 24, 469–477 (2009).
Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C. & Kent, R. L. Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25, 134–1442 (1998).
Hajishengallis, G. & Lamont, R. J. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328–338 (2014).
Rodenburg, J. P. et al. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history. J. Clin. Periodontol. 17, 392–399 (1990).
Slots, J. & Ting, M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: Occurrence and treatment. Periodontol. 2000(20), 82–121 (1999).
Müller, H. P. et al. Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis. J. Periodontal. Res. 33, 49–58 (1998).
Mombelli, A., Casagni, F. & Madianos, P. N. Can presence or absence of periodontal pathogens distinguish between subjects with chronic and aggressive periodontitis? A systematic review. J. Clin. Periodontol. 29(Suppl 3), 10–21 (2002).
Nieminen, A. et al. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis. J. Clin. Periodontol. 23, 572–581 (1996).
Chapple, I. L. C. et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 89(Suppl. 1), S74–S84 (2018).
Slots, J. & Ting, M. Systemic antibiotics in the treatment of periodontal disease. Periodontol. 2000(28), 106–176 (2002).
Zandbergen, D., Slot, D. E., Niederman, R. & Van der Weijden, F. A. The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: A systematic review. BMC Oral Health 16, 27–38 (2016).
Preus, H. R. & Baelum, V. Letter to the editor. J. Periodontol. 85, 374–384 (2014).
Van Winkelhoff, A. J., Rams, T. E. & Slots, J. Systemic antibiotic therapy in periodontics. Periodontol. 2000(10), 45–78 (1996).
Boutaga, K., Van Winkelhoff, A.J., Vandenbroucke-Grauls, C.M., Savelkoul, P.H. The additional value of real-time PCR in the quantitative detection of periodontal pathogens. J. Clin. Periodontol. 33, 427–332006.
Untch, M. & Schlagenhauf, U. Inter-and intra-test agreement of three commercially available molecular diagnostic test for the identification of periodontal pathogens. Clin. Oral Invest. 19, 2045–2052 (2015).
Santigli, E. et al. Accuracy of commercial kits and published primer pairs for the detection of periodontopathogens. Clin. Oral Invest. 20, 2515–2528 (2016).
Van der Weijden, G. A., Dekkers, G. J. & Slot, D. E. Success of non-surgical periodontal therapy in adult periodontitis patients: A retrospective analysis. Int. J. Dent. Hyg. 17, 309–317 (2019).
Boutaga, K., Van Winkelhoff, A. J., Vandenbroucke-Grauls, C. M. & Savelkoul, P. H. Periodontal pathogens: A quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol. Med. Microbiol. 45, 191–199 (2005).
Gunsolley, J. C. et al. Analysis of site specific periodontal bacteria sampling schemes. J. Periodontol. 63, 507–514 (1992).
Mombelli, A., McNabb, H., Lang, N.P. Black-pigmenting gram-negative bacteria in periodontal disease. II. Screening strategies for detection of P. gingivalis. J. Periodontal. Res. 26, 308–313 (1991).
Timmerman, M. F. et al. How do data from deepest pocket per quadrant relate to full-mouth scores? Progression of untreated periodontal disease in young Indonesians. J. Clin. Periodontol. 29, 219–223 (2002).
Nickles, K., Scharf, S., Röllke, L., Dannewitz, B. & Eickholz, P. Comparison of two different sampling methods for subgingival plaque: Subgingival paper points or mouthrinse sample?. J. Periodontol. 88, 399–406 (2017).
R Core Team. R: A language and environment for statistical computing [Internet], Vienna. http://www.r-project.org/. Accessed 31 Dec 2020.
The jamovi project. jamovi. (Version 1.2) [Computer Software]. https://www.jamovi.org. Accessed 31 Dec 2020.
Papapanou, P. N. et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 45(Suppl 20), S162–S170 (2018).
Teles, R., Teles, F., Frias-Lopez, J., Paster, B. & Haffajee, A. Lessons learned and unlearned in periodontal microbiology. Periodontol. 2000(62), 95–162 (2013).
Do, T., Devine, D. & Marsh, P. D. Oral biofilms: Molecular analysis, challenges, and future prospects in dental diagnostics. Clin. Cosmet. Invest. Dent. 28, 11–19 (2013).
Aruni, W., Chioma, O. & Fletcher, H. M. Filifactor alocis: The newly discovered kid on the block with special talents. J. Dent. Res. 93, 725–732 (2014).
Loomer, P. M. Microbiological diagnostic testing in the treatment of periodontal diseases. Periodontol. 2000(34), 49–56 (2004).
Guerrero, A. et al. Impact of baseline microbiological status on clinical outcomes in generalized aggressive periodontitis patients treated with or without adjunctive amoxicillin and metronidazole: an exploratory analysis from a randomized controlled clinical trial. J. Clin. Periodontol. 41, 1080–1089 (2014).
Van Winkelhoff, A. J. & Winkel, E. G. Diagnostics in Periodontology Microbiological parameters. Biological significance and clinical validity. Periodontol. 2000(39), 40–52 (2005).
Winkel, E.G., Van Winkelhoff, A.J., Timmerman, M.F., Van der Velden U, Van der Weijden, G.A. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J. Clin. Periodontol. 28, 296–305 (2001).
Salkin, L.M., Freedman, A.L., Mellado, J.R., Stein, M.D., Schneider, D.B. et al. The clinical relevance of microbiologic testing. Part 2: A comparative analysis of microbiologic samples secured simultaneously from the same sites and cultured in the same laboratory. Int. J. Periodontics Restorative Dent. 23, 121–127 (2003).
Rautemaa-Richardson, R., Van der Reijden, W. A., Dahlen, G. & Smith, A. J. Quality control for diagnostic oral microbiology laboratories in European countries. J. Oral. Microbiol. 3, 8395 (2011).
Bartold, P. M. & Van Dyke, T. E. An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis. J. Clin. Periodontol. 46, 6–11 (2019).
Colombo, A. P. V. & Tanner, A. C. R. The role of bacterial biofilms in dental caries and periodontal and peri-implant diseases: A historical perspective. J. Dent. Res. 98, 373–385 (2019).
Wennström, J. L., Dahlén, G., Svensson, J. & Nyman, S. Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius: predictors of attachment loss?. Oral Microbiol. Immunol. 2, 158–162 (1987).
Nagarajan, R., Miller, C.S., Dawson. D. III, Ebersole. J.L. Biologic modelling of periodontal disease progression. J. Clin. Periodontol. 46, 160–169 (2019).
Torres, P. J., Thompson, J., McLean, J. S., Kelley, S. T. & Edlund, A. Discovery of a novel periodontal disease-associated bacterium. Microb. Ecol. 77, 267–276 (2019).
Acknowledgements
The authors thank Arie Jan van Winkelhoff and Paul Savelkoul for their help and critical thoughts while preparing this manuscript.
Funding
This retrospective analysis was not funded. All three test kits were commercially obtained by the Clinic for Periodontology Utrecht.
Author information
Authors and Affiliations
Contributions
All authors gave final approval and agreed to be accountable for all aspects of work ensuring integrity and accuracy. F.V.d.W.: contributed to conception and design, analysis and interpretation, and drafted the manuscript. M.R.: contributed to design, analysis and interpretation, and advised on content of the manuscript. C.V.: contributed to statistical analysis and interpretation, and advised on content of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Van der Weijden, F., Rijnen, M. & Valkenburg, C. Comparison of three qPCR-based commercial tests for detection of periodontal pathogens. Sci Rep 11, 6141 (2021). https://doi.org/10.1038/s41598-021-85305-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-85305-3
- Springer Nature Limited